Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > As you know, THOMVEST is at elm of LMNL

<< Previous

Bullboard Posts

Next >>

Comment by Thesweethearton Nov 07, 2019 9:59am

34 Views

Post# 30320757

RE:As you know, THOMVEST is at elm of LMNL

Going Down! Just like the titanic!!!no rest for the wicked.

Newcamo wrote:
since 6 months only...let them operate lmnl for 18-24 months, u will love it....major NR bringing 77 million$ in lmnl nov 4th, with volume lmnl will move...nasdaq confirmed this quarter:

"...its common shares will commence trading on the NASDAQ and Toronto Stock Exchange under the new name in the fourth quarter of 2019."

https://resources.liminalbiosciences.com/press-releases-2019-2/prometic-life-sciences-announces-intention-to-change-name-to-liminal-biosciences-inc

trust the plan...tag along....owners have 85% of all shares